Switzerland (CH)

Immobilization by 21-days of bed rest causes changes in biomarkers of cartilage homeostasis in healthy individuals (2025) Dreiner M, Godonou ET, Mündermann A, Tascilar K, Schett G, Zaucke F, Liphardt AM, Niehoff A Journal article MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma (2025) Friker LL, Perwein T, Waha A, Dörner E, Klein R, Blattner-Johnson M, Layer JP, et al. Journal article Continuing medical education in epileptology: The Level 1-2-3 experience of the ILAE academy (2025) Blümcke I, Biesel E, Wiebe S, Beniczky S, Wilmshurst JM, Mehndiratta MM, Asadi-Pooya AA, et al. Journal article Dermatologist-like explainable AI enhances melanoma diagnosis accuracy: eye-tracking study (2025) Chanda T, Haggenmueller S, Bucher TC, Holland-Letz T, Kittler H, Tschandl P, Heppt M, et al. Journal article Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantification (2025) Galas K, Gleitsmann M, Rey J, Solbach C, Witzel I, Karn T, Schmatloch S, et al. Journal article Charge Radii of Neutron-Rich Scandium Isotopes and the Seniority Symmetry in the 0f7/2 Shell (2025) Bai SW, Yang XF, Koszorús , Berengut JC, Billowes J, Bissell ML, Blaum K, et al. Journal article Correction to: Environmental consequences of interacting effects of changes in stratospheric ozone, ultraviolet radiation, and climate: UNEP Environmental Effects Assessment Panel, Update 2024 (Photochemical & Photobiological Sciences, (2025), 24, 3, (357-392), 10.1007/s43630-025-00687-x) (2025) Neale PJ, Hylander S, Banaszak AT, Häder DP, Rose KC, Vione D, Wängberg SÅ, et al. Journal article, Erratum Practical and statistical aspects of subgroup analyses in surgical neuro-oncology: A comprehensive review from the PIONEER consortium (2025) Gerritsen JK, Karschnia P, Young JS, Van Den Bent MJ, Chang SM, Smith TR, Nahed BV, et al. Journal article Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD-Long-term Survival of the GeparOLA Study (2025) Fasching P, Schmatloch S, Hauke J, Rey J, Jackisch C, Klare P, Link T, et al. Journal article Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial (2025) Fasching P, Slamon D, Nowecki Z, Kukielka-Budny B, Stroyakovskiy D, Yardley DA, Huang CS, et al. Journal article